Nitric oxide inhalation therapy in very low-birthweight infants with hypoplastic lung due to oligohydramnios

Pediatrics International

Volumn 46, Issue 1, 2004, Pages 10-14

  Uga, Naoki ^a   Ishii, Tetsuya ^a   Kawase, Yasuhiro ^a   Arai, Hiroko ^a   Tada, Hiroshi ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Nitric oxide inhalation therapy; Oligohydramnios; Persistent pulmonary hypertension of newborn; Pulmonary hypoplasia; Very low birthweight infant

Indexed keywords

LUNG SURFACTANT; NITRIC OXIDE;

AIRWAY PRESSURE; ARTERIAL OXYGEN SATURATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; HUMAN; LOW BIRTH WEIGHT; LUNG HYPOPLASIA; NEWBORN; OLIGOHYDRAMNIOS; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ASPHYXIA NEONATORUM; BRONCHODILATOR AGENTS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; JAPAN; LUNG; NITRIC OXIDE; OLIGOHYDRAMNIOS; PREGNANCY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 1542721843     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2004.01844.x     Document Type: Article

References (13)

1. Meurs KP, Rhine WD, Asselin JM, Durand DJ. Response of premature infants with severe respiratory failure to inhaled nitric oxide. Preemie NO Collaborative Group. Pediatr. Pulmonol. 1997; 24: 319-23.
2. Cheung PY, Peliowski A, Robertson CM. The outcome of very low birth weight neonates (
3. Ishii T. The research of nitric oxide therapy on low birth weight infants. Acta Neonat. Jpn. 2002; 38: 52-9.
4. Thibeault DW, Beatty EC Jr, Hall RT, Bowen SK, O'Neill DH. Neonatal pulmonary hypoplasia with premature rupture of fetal membranes and oligohydramnios. J. Pediatr. 1985; 107: 273-7.
5. McIntosh N, Harrison A. Prolonged premature rupture of membranes in the preterm infant: a 7 year study. Eur. J. Obstet. Gynecol. Reprod. Biol. 1994; 57: 1-6.
6. Subhedar NV, Ryan SW, Shaw NJ. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch. Dis. Child Fetal Neonatal Ed. 1997; 77: F185-90.
7. The Franco-Belgium Collaborative NO Trial Group. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet 1999; 354: 1066-71.
8. Kinsella JP. Clinical trials of inhaled nitric oxide therapy in the newborn. Pediatr. Rev. 1999; 20: 110-13.
9. McIntosh N. Dry lung syndrome after oligohydramnios. Arch. Dis. Child 1988; 63: 190-3.
10. Losa M, Kind C. Dry lung syndrome: complete airway collapse mimicking pulmonary hypoplasia? Eur. J. Pediatr. 1998; 157: 935-8.
11. Bassenge E. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors. Eur. Heart J. 1991; 12 (Suppl. E): 12-15.
12. Hogman M, Frostell C, Arnberg H, Sandhagen B, Hedenstierna G. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol. Scand. 1994; 151: 125-9.
13. Clark RH, Kueser TJ, Walker MW et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N. Engl. J. Med. 2000; 342: 469-74.